Pharmaceutical Executive

Darrell Wakefield, Franchise Head, Solid Tumor, Sanofi Genzyme, talks creative impact on brand success.

Since 2008, Pharmaceutical Executive has recognized a class of biopharma professionals to receive the title Emerging Pharma Leader. This year, along with their profiles in our May issue, our editorial team presents a webcast featuring the winners and their up-and-coming perspectives on a range of industry topics.
Get a full list of our #2021EPL and read their profiles here:https://www.pharmexec.com/view/epl-2021

Sandor Schoichet, an independent advisor, and director of Meridian Management Consultants based in San Francisco, and Pharm Exec’s Sustainability columnist, and his co-collaborator, Thomas Scheiwiller, an independent advisor and board member based in Zurich, discuss many of the topics we touch on today in regard to biopharma’s approach to integrating environmental, social, and governance, or ESG, issues into business strategy.

Shaheed Peera, President, Founder and CEO of The Creative Floor Awards, London, and Global Creative Lead for Reckitt Benckiser ECom, talks about inspiring award-winning creative, reflects on his time as President on Cannes, and provides some insight on his award show The Creative Floor as well as a few tips about the inaugural PharmExec APEX Awards
Submit your PE APEX nominations here: https://apex.pharmexec.com/pages/apex-home?utm_source=linkedin&utm_medium=social&utm_campaign=PE

Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer research going throughout the pandemic.

John Furey, CEO of Imvax and an Editorial Advisory Board member for Pharm Exec, discusses some leadership principles he learned while playing rugby as a young man in Ireland, and how those tenets can translate to the C-suite.

Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics, shares his experience after he became stranded in Nigeria for five months and the valuable leadership lessons he learned.

Paul Shawah, Executive Vice President of Strategy at Veeva Systems, looks back at the past year of the pandemic to see the digital transformation of pharma’s interaction with healthcare professionals.

Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.

Joel Marcus, founder and executive chairman of Alexandria Real Estate Equities, and founder and CEO of Alexandria Venture Investments, discusses the drive to bring pharma manufacturing back to a company’s home country and the issues involved in doing so.